Clinical Trial Update: Effect of High-dose Target-controlled Naloxone Infusion on Pain and Hyperalgesia During a Burn Injury [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial studying high-dose target-controlled naloxone infusion for pain and hyperalgesia in burn injury, completed in healthy subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burn Injury
• Healthy Subject Condition

Drugs mentioned

• Naloxone (Naloxone)

Snippet

Sponsor: mads u werner | Conditions: Healthy Subjects | Phase 2 | Status: COMPLETED